MajesTEC-4
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4
Arms / Cohorts
Experimental:Arm A: Teclistamab-Lenalidomide (Tec-Len)
Not currently accepting
Active Comparator:Arm B: Lenalidomide Alone (Len)
Not currently accepting
Experimental:Arm C: Teclistamab-Alone (Tec)
Not currently accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.